Lexicon Pharmaceuticals
LXRX
LXRX
127 hedge funds and large institutions have $471M invested in Lexicon Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 20 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more ownership
Funds ownership: 70.17% → 77.17% (+7%)
7% more funds holding
Funds holding: 119 → 127 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
127
Holding in Top 10
1
Calls
$4.21M
Puts
$622K
Top Buyers
| 1 | +$96.7M | |
| 2 | +$41.7M | |
| 3 | +$13.9M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.94M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.87M |
Top Sellers
| 1 | -$4.05M | |
| 2 | -$3.37M | |
| 3 | -$2.2M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$766K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$704K |